laquinimod topical (TV-5600) / Active Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  laquinimod topical (TV-5600) / Active Biotech
    Trial completion date, Trial primary completion date, Immunomodulating:  Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study (clinicaltrials.gov) -  Jul 11, 2024   
    P1,  N=12, Recruiting, 
    Trial completion date: Oct 2024 --> Feb 2025 | Trial primary completion date: Aug 2024 --> Dec 2024
  • ||||||||||  laquinimod topical (TV-5600) / Active Biotech
    Enrollment open, Immunomodulating:  Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study (clinicaltrials.gov) -  Mar 29, 2024   
    P1,  N=12, Recruiting, 
    Trial completion date: Oct 2024 --> Feb 2025 | Trial primary completion date: Aug 2024 --> Dec 2024 Not yet recruiting --> Recruiting
  • ||||||||||  laquinimod topical (TV-5600) / Active Biotech
    Trial completion:  A Study of Laquinimod Eye-drops in Healthy Participants (clinicaltrials.gov) -  Jan 31, 2023   
    P1,  N=54, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed
  • ||||||||||  laquinimod topical (TV-5600) / Active Biotech
    Enrollment closed:  A Study of Laquinimod Eye-drops in Healthy Participants (clinicaltrials.gov) -  Jan 18, 2023   
    P1,  N=56, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  laquinimod topical (TV-5600) / Active Biotech
    Enrollment change, Trial completion date, Trial primary completion date:  A Study of Laquinimod Eye-drops in Healthy Participants (clinicaltrials.gov) -  Aug 11, 2022   
    P1,  N=56, Recruiting, 
    Recruiting --> Active, not recruiting N=42 --> 56 | Trial completion date: Jun 2022 --> Mar 2023 | Trial primary completion date: May 2022 --> Jan 2023